Subarachnoid Hemorrhage
Medscape Aug, Becske, T. & Lutsep, H.L., 2016
Pembrolizumab-Induced Myasthenia Gravis
Neurol 91:e1365-e1367, Algaeed, M.,et al, 2018
Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Cluster Headache
BMJ 344:e2407, Nesbitt,A.D.,et al, 2012
Neurotoxicity of Commonly Used Antineoplastic Agents
NEJM 291:75, 1271974., Weiss,H.,et al, 1974
Cavernous Sinus Thrombosis
StatPearls PMID:28846357, Plewa,M.C.,et al, 2023
Useful Bedside Testing for Myasthenia Gravis
Neurol 94:e1870-e1871, Gomes del Carvalho Neto, E.,et al, 2020
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
A 23-Year-Old Man with Headaches, Confusion, and Lower Extremity Weakness
Neurol 92:863-867, Patel, N.M.,et al, 2019
Immune Checkpoint Inhibitor-Related Myositis and Myocarditis in Patients with Cancer
Neurol 91:e985-e994, Touat, M.,et al, 2018
A 44-year-old Woman with Rapidly Progressive Weakness and Ophthalmoplegia
Neurol 85:e22-e27, Schreck, K.C.,et al, 2015
Severe Botulism After Focal Injection of Botulinum Toxin
Neurol 67:1855-1856, Souayah,N.,et al, 2006
Botulism in 4 Adults Following Cosmetic Injections With an Unlicensed, Highly Concentrated Botulinum Preparation
JAMA 296:2476-2479,2512, Chertow,D.S.,et al, 2006
Mitochondrial DNA Polymerase-y and Human Disease
Hum Mol Genet 15:R244-R252, Hudson, G.,et al, 2006
Ptosis as a Remote Effect of Therapeutic Botulinum Toxin B Injection
Neurol 59:1445-1447, Racette,B.A.,et al, 2002
A Practical Approach to the Diagnosis and Management of MELAS: Case Report and Review
The Neurologist 8:302-312, Thambisetty,M.,et al, 2002
Oculopharyngeal Muscular Dystrophy in Hispanic New Mexicans
JAMA 286:2437-2440, Becher,M.W.,et al, 2001
Headache: Cortical Vein Thrombosis and Response to Anticoagulation
J Emerg Med 17:449-453, Minadeo,J.P &Karaman,B.A., 1999
Mitochondrial DNA and Disease
NEJM 333:638-644, Johns,D.R., 1995
Lambert-Eaton Myasthenic Syndrome:Clinical Diagnosis,Immune-Mediated Mechanisms,and Update on Therapies
Ann Neurol 37:S63-S73, Sanders,D.B., 1995
Ocular Myasthenia:A Protean Disorder
Survey of Ophthalmology 39:169-210, Weinberg,D.A.,et al, 1994
Treatment of Hemifacial Spasm with Botulinum Toxin
Muscle & Nerve 15:1045-1049992., Yoshimura,D.M.,et al, 1992
Hypothyroidism
In Neurologic Clinics, W. B. Saunders Co, Phila, 7:492-493., Kaminski,H.J.&Ruff,R.L., 1989
Clinicopath Conf
Lymphoma, Large-Cell (B type) of CNS, (Temporal & Frontal Lobes, Br Stem, Sp Cord, Meninges, & Nr Ro, t) , Case RecM 319:426-436,1988., 1988
Wernicke's Encephalopathy
NEJM 312:1035-1039, Reuler,J.B.,et al, 1985
Neurological Aspects of Thyroid Dysfunction
Mayo Clin Proc 56:504-512, Swanson,J.W.,et al, 1981
Chronic Paroxysmal Hemicrania:A Disabling Headache Syndrome Responding to Indomethacin
Ann Neurol 3:183, Price,R.W.,et al, 1978
Myasthenia Gravis Assoc. with Wasp Sting
JAMA 235:2120, Brumlik,J., 1976
Neuropsychiatric Manifest. of SLE:Diagnosis, Clinical Spectrum, & Relationship to Other Features of the Disease
Medicine 55:323, Feinglass,E.J.,et al, 1976
Vincristine Neurotoxicity
Ann Int Med 80:733-737, Rosenthal,S.,et al, 1974
Narcolepsy
NEJM 288:1156, Zarcone,V., 1973
Neurosyphilis
JAMA 219:726, Hooshmand,H.,et al, 1972
Whipple's Disease & Papilledema
Arch Int Med 123:74, Switz,D.M.,et al, 1969